$AMS

ams OSRAM (SIX: AMS) has joined the Short-Reach Micro-Emitter Optics (SRMO) workstream led by Credo, part of the Open Compute Project (OCP). The initiative aims to standardize optical interconnects for AI infrastructure, leveraging ams OSRAM's microLED, microVCSEL, and microPhotodiode technologies. The company sees this as a growth opportunity in AI data centers, aligning with its Digital Photonics strategy. The SRMO specification is targeted for OCP approval in 2027.

South Africa demands Zimbabwe repay $228M owed to platinum miners. Minister Mantashe seeks repayment of 30% deducted from PGM producers. Zimbabwe's policy retains export proceeds, causing cash-flow strains. Valterra Platinum and Impala Platinum report significant outstanding balances. Zimbabwe is the world's third-largest PGM producer.

American Shared Hospital Services (NYSE American: AMS) reported a Q2 2026 net loss of $514,000, or $0.07 per diluted share, widening from a $280,000 loss a year earlier, despite revenue rising 19.2% to $8.43 million. Direct patient services drove growth, while gross profit and operating loss worsened. Cash rose to $6.511 million at June 30, 2026, and the company later arranged financing with Fifth Third Bank.

American Shared Hospital Services (AMS) reported Q2 2026 earnings call highlights including 19% year-over-year revenue growth driven by direct patient services, higher international Gamma Knife volumes, and improving proton beam performance. Proton beam revenue rose 22% to about $2.3M in the quarter and $4.3M for six months. Reported results were impacted by $285k legal costs and a $909k credit-loss allowance. Cash equivalents and restricted cash were about $6.8M.

American Shared Hospital Services (NYSE: AMS) reported Q2 2026 revenue of $8.43M and $15.51M for the first half, up from $7.07M and $13.18M a year earlier, driven by direct patient services and higher PBRT and Gamma Knife volumes. The company posted net losses of $0.51M in Q2 and $1.13M for six months and disclosed substantial doubt about its going concern due to covenant breaches and debt default notices.

American Shared Hospital Services reported Q2 2026 sales of $8.43 million versus $7.07 million a year earlier. Net loss was $0.514 million versus $0.28 million. Basic and diluted loss per share were $0.07 versus $0.04. For six months, sales rose to $15.51 million from $13.18 million, with net loss of $1.13 million versus $0.905 million.

American Shared Hospital Services (AMS) reported Q2 2026 revenue up 19% year over year to $8.4M, citing growth in Direct Patient Services and international markets. The company said cash generation was strong, but noted a $909K credit loss and refinancing needs as key risks. It attributed the outlook to strategic investments and operational improvements.

American Shared Hospital Services reported Q2 2026 revenue of $8.4 million, up 19.2% year over year and above the $7.56 million forecast. Adjusted EPS was a loss of $0.07 versus an expected loss of $0.02. Direct patient services rose to $4.9 million and proton beam revenue to about $2.3 million. Cash and equivalents were $6.8 million; management discussed refinancing debt due in 2027.

American Shared Hospital Services (AMEX: AMS) reported Q2 2026 revenue of $8.4 million, up 19% year over year. Direct patient services rose about 40% to $4.9 million, while Proton Beam Radiation Therapy revenue increased 22% to about $2.3 million. Adjusted EBITDA fell to about $1.3 million from $1.7 million. Cash increased to $6.8 million by quarter end.

AMERICAN SHARED HOSPITAL SERVICES (AMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 American Shared Hospital Services Reports Second Quarter and First Half 2026 Financial Results Second Quarter Revenue Increased 19% to $8.4 Million Driven by Strong Growth from Direct Patient Services Operating Cash Flow Reached $4.4 Million in First Half of 2026 Con